CN110945006A - 用于制备胆汁酸衍生物的方法和中间体 - Google Patents

用于制备胆汁酸衍生物的方法和中间体 Download PDF

Info

Publication number
CN110945006A
CN110945006A CN201880047896.5A CN201880047896A CN110945006A CN 110945006 A CN110945006 A CN 110945006A CN 201880047896 A CN201880047896 A CN 201880047896A CN 110945006 A CN110945006 A CN 110945006A
Authority
CN
China
Prior art keywords
compound
formula
acid
reacting
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880047896.5A
Other languages
English (en)
Chinese (zh)
Inventor
R·佩里恰里
A·焦伊洛
加布里埃尔·加尔文
罗纳德·D·路易斯
马修·亚尼克
金明九
弗雷德·罗纳德·莱乌辛克
巴尔特吉安·科宁
托马斯·亨塞尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intercept Pharmaceuticals Inc
Original Assignee
Intercept Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercept Pharmaceuticals Inc filed Critical Intercept Pharmaceuticals Inc
Publication of CN110945006A publication Critical patent/CN110945006A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
CN201880047896.5A 2017-06-23 2018-06-22 用于制备胆汁酸衍生物的方法和中间体 Pending CN110945006A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762523937P 2017-06-23 2017-06-23
US62/523,937 2017-06-23
PCT/US2018/039148 WO2018237350A1 (en) 2017-06-23 2018-06-22 METHODS AND INTERMEDIATES FOR PREPARING BILARY ACID DERIVATIVES

Publications (1)

Publication Number Publication Date
CN110945006A true CN110945006A (zh) 2020-03-31

Family

ID=64691408

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880047896.5A Pending CN110945006A (zh) 2017-06-23 2018-06-22 用于制备胆汁酸衍生物的方法和中间体

Country Status (10)

Country Link
US (2) US11066437B2 (enExample)
EP (1) EP3642217A4 (enExample)
JP (1) JP7224307B2 (enExample)
KR (2) KR102831293B1 (enExample)
CN (1) CN110945006A (enExample)
AU (1) AU2018288883B2 (enExample)
BR (1) BR112019027458A2 (enExample)
CA (1) CA3067219A1 (enExample)
IL (2) IL271343B2 (enExample)
WO (1) WO2018237350A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112795615A (zh) * 2021-02-03 2021-05-14 湖南醇康医药科技有限公司 一种诱变菌种以及微生物发酵制备熊去氧胆酸的方法
CN114045239A (zh) * 2021-11-08 2022-02-15 浙江树人学院（浙江树人大学） 具有二甲基乙酰胺降解能力的泛养副球菌ybh-7及应用

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013036835A1 (en) 2011-09-08 2013-03-14 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
RS67266B1 (sr) 2013-03-13 2025-10-31 Sage Therapeutics Inc Neuroaktivni steroidi i postupci za njihovu upotrebu
WO2015195967A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
SMT202100476T1 (it) 2015-07-06 2021-09-14 Sage Therapeutics Inc Ossisteroli e metodi di uso degli stessi
JP6882996B2 (ja) 2015-07-06 2021-06-02 セージ セラピューティクス， インコーポレイテッド オキシステロールおよびそれらの使用の方法
BR112018000129B1 (pt) 2015-07-06 2024-01-09 Sage Therapeutics, Inc Compostos oxiesteróis, seus usos e composição farmacêutica
TN2018000106A1 (en) * 2015-10-07 2019-10-04 Intercept Pharmaceuticals Inc Farnesoid x receptor modulators
SI3436022T1 (sl) 2016-04-01 2022-08-31 Sage Therapeutics, Inc. Oksisteroli in postopki za uporabo le-teh
WO2017193046A1 (en) 2016-05-06 2017-11-09 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
ES2884071T3 (es) 2016-07-07 2021-12-10 Sage Therapeutics Inc 24-hidroxiesteroles sustituidos en 11 para el tratamiento de afecciones relacionadas con NMDA
MX392270B (es) 2016-09-30 2025-03-24 Sage Therapeutics Inc Oxisteroles sustituidos en c7 y metodos de uso de los mismos.
CN110267966B (zh) 2016-10-18 2022-07-08 萨奇治疗股份有限公司 氧甾醇及其使用方法
EP4105223B1 (en) 2016-10-18 2025-04-30 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ，インク． Ｇｐｒ１１９アゴニスト
WO2021155167A1 (en) * 2020-01-31 2021-08-05 The Johns Hopkins University Bile acid-gcpii inhibitor conjugates to treat inflammatory diseases
PH12022552277A1 (en) 2020-02-28 2024-03-04 Kallyope Inc Gpr40 agonists
US12215127B2 (en) 2020-04-17 2025-02-04 Cornell University Compositions and methods for profiling of gut microbiota-associated bile salt hydrolase (BSH) activity
CA3178994A1 (en) 2020-05-19 2021-11-25 Iyassu Sebhat Ampk activators
JP2023531726A (ja) 2020-06-26 2023-07-25 キャリーオペ，インク． Ａｍｐｋアクチベーター
WO2023288123A1 (en) * 2021-07-16 2023-01-19 Interecept Pharmaceuticals, Inc. Methods and intermediates for the preparation of 3.alpha.,7.alpha.,11.beta.-trihydroxy-6.alpha.-ethyl-5.beta.-cholan-24-oic acid
AU2023257308A1 (en) * 2022-04-21 2024-10-10 Intercept Pharmaceuticals, Inc. Uses of farnesoid x receptor agonists
WO2024163640A2 (en) * 2023-02-01 2024-08-08 Intercept Pharmaceuticals, Inc. Methods and intermediates for the preparation of bile acid derivatives

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2554882A (en) * 1943-02-04 1951-05-29 Reichstein Tadeus 3-hydroxy-11-ketoetiocholanic acid and its esters
US3277121A (en) * 1964-05-04 1966-10-04 Canada Packers Ltd Conversion of delta11-steroids to 11-oxygenated steroids
DE3040634A1 (de) * 1980-10-29 1982-05-27 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung von 3 (alpha) -hydroxy-5- (beta) -pregnan-11,20-dion
WO2014184271A1 (en) * 2013-05-14 2014-11-20 Tes Pharma Srl. 11-hydroxyl-derivatives of bile acids and amino acid conjugates thereof as farnesoid x receptor modulators
WO2017062763A1 (en) * 2015-10-07 2017-04-13 Intercept Pharmaceuticals, Inc. Farnesoid x receptor modulators

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2403683A (en) * 1942-04-25 1946-07-09 Relchstein Tadeus Compounds of the cyclopentanopolyhydrophenanthrene series and process of making same
DE10113257C1 (de) 2001-03-19 2002-11-14 Inst Mikrotechnik Mainz Gmbh Elektrophoresevorrichtung und ihre Verwendung
US20080318870A1 (en) 2007-06-19 2008-12-25 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
CA2966885A1 (en) 2014-11-06 2016-05-12 Enanta Pharmaceuticals, Inc. Bile acid analogs an fxr/tgr5 agonists and methods of use thereof
WO2016086115A1 (en) 2014-11-26 2016-06-02 Enanta Pharmaceuticals, Inc. Tetrazole derivatives of bile acids as fxr/tgr5 agonists and methods of use thereof
US10208081B2 (en) 2014-11-26 2019-02-19 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
HK1244708A1 (zh) 2014-11-26 2018-08-17 英安塔制药有限公司 作爲fxr/tgr5激动剂的胆汁酸类似物及其使用方法
RU2017130466A (ru) 2015-02-11 2019-03-12 Энанта Фармасьютикалс, Инк. Аналоги желчной кислоты в качестве агонистов fxr/tgr5 и способы их применения
NZ735126A (en) 2015-03-31 2022-10-28 Enanta Pharm Inc Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
BR112018002499A2 (pt) 2015-08-07 2018-09-18 Intercept Pharmaceuticals Inc método de preparação de um composto da fórmula (a) ou um seu sal, solvato ou conjugado de aminoácido farmaceuticamente aceitável, composto produzido pelo método e composição farmacêutica
CN107973834A (zh) 2016-10-22 2018-05-01 合帕吉恩治疗公司 作为fxr/tgr5调节剂的胆酸衍生物
US10597391B2 (en) 2016-10-26 2020-03-24 Enanta Pharmaceuticals, Inc. Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2554882A (en) * 1943-02-04 1951-05-29 Reichstein Tadeus 3-hydroxy-11-ketoetiocholanic acid and its esters
US3277121A (en) * 1964-05-04 1966-10-04 Canada Packers Ltd Conversion of delta11-steroids to 11-oxygenated steroids
DE3040634A1 (de) * 1980-10-29 1982-05-27 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung von 3 (alpha) -hydroxy-5- (beta) -pregnan-11,20-dion
WO2014184271A1 (en) * 2013-05-14 2014-11-20 Tes Pharma Srl. 11-hydroxyl-derivatives of bile acids and amino acid conjugates thereof as farnesoid x receptor modulators
WO2017062763A1 (en) * 2015-10-07 2017-04-13 Intercept Pharmaceuticals, Inc. Farnesoid x receptor modulators

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LEWIS HASTINGS SARETT: "PARTIAL SYNTHESIS OF PREGNENE-4-TRIOL-17(β),20(β),21-DIONE-3,11 AND PREGNENE-4-DIOL-17(β),21-TRIONE-3,11,20 MONOACETATE", 《JOURNAL OF BIOLOGICAL CHEMISTRY》 *
VON A. LARDON, T. REIEHSTEIN: "Über Gallensäuren und verwandte Stoffe. 35. Mitteilung1). 3α-Acetoxy-nor-, bisnor- und -ätio-cholen-(9)-säure-methylester", 《HELVETICA CHIMICA ACTA》 *
VON G. H. OTT, T. REICHSTEIN: "Über Gallensäuren und verwandte Stoffe. 27. Mitteilung. α-Oxyde der beiden 3-Oxy- und der 3-Keto-cholen-(11)-säure", 《HELVETICA CHIMICA ACTA》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112795615A (zh) * 2021-02-03 2021-05-14 湖南醇康医药科技有限公司 一种诱变菌种以及微生物发酵制备熊去氧胆酸的方法
CN114045239A (zh) * 2021-11-08 2022-02-15 浙江树人学院（浙江树人大学） 具有二甲基乙酰胺降解能力的泛养副球菌ybh-7及应用
CN114045239B (zh) * 2021-11-08 2023-09-29 浙江树人学院（浙江树人大学） 具有二甲基乙酰胺降解能力的泛养副球菌ybh-7及应用

Also Published As

Publication number Publication date
IL271343B1 (en) 2023-08-01
BR112019027458A2 (pt) 2020-07-07
CA3067219A1 (en) 2018-12-27
KR20250109791A (ko) 2025-07-17
WO2018237350A1 (en) 2018-12-27
JP7224307B2 (ja) 2023-02-17
AU2018288883A1 (en) 2020-01-16
US11066437B2 (en) 2021-07-20
IL271343B2 (en) 2023-12-01
AU2018288883B2 (en) 2022-06-02
EP3642217A1 (en) 2020-04-29
US20220127302A1 (en) 2022-04-28
IL271343A (en) 2020-01-30
KR20200020877A (ko) 2020-02-26
KR102831293B1 (ko) 2025-07-08
US20180371009A1 (en) 2018-12-27
JP2020525426A (ja) 2020-08-27
IL304455A (en) 2023-09-01
EP3642217A4 (en) 2021-06-16

Similar Documents

Publication Publication Date Title
CN110945006A (zh) 用于制备胆汁酸衍生物的方法和中间体
AU2016335765B2 (en) Farnesoid X receptor modulators
CN110003301B (zh) 用于治疗和/或预防fxr和tgr5/gpbar1介导的疾病的胆烷衍生物
CN107531743A (zh) 鹅去氧胆酸衍生物
WO2016173493A1 (en) Sulfonylaminocarbonyl derivative, pharmaceutical composition and uses thereof
Poza et al. Synthesis and evaluation of new 6-hydroximinosteroid analogs as cytotoxic agents
CA2993540A1 (en) Methods for preparation of bile acids and derivatives thereof
FI66010C (fi) Foerfarande foer framstaellning av nya vid avbrytande av havandeskap anvaendbara 4- och/eller 6-alkylerade 4alfa 5alfa-epoxi-2alfa-cyan-3-oxosteroid-derivat
CN103787942B (zh) 一种制备鲁比前列酮的中间体、其制备方法以及通过其制备鲁比前列酮的方法
CN114315855A (zh) 莪术醇类衍生物、制备方法及其在制备抗炎药物中的应用
CN114716497A (zh) 一种制备脱氧胆酸的方法
CN101508717B (zh) 抗结核化合物帕格甾醇的合成方法
WO2024163640A2 (en) Methods and intermediates for the preparation of bile acid derivatives
CN109305956A (zh) 五层龙属植物中提取的锍鎓盐类天然产物neoponkoranol克级别的全合成方法
CN104830943B (zh) 一种艾尔骨化醇中间体的制备方法
CN114805454B (zh) α-半乳糖神经酰胺类化合物及其制备方法和用途
US20110306629A1 (en) Novel c-1 analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation
CN103387539A (zh) 4-苄氧基-17-乙酰基吗啡喃-6-酮的合成
Bunyathaworn et al. Synthesis and Cytotoxicity Studies of Polyhydroxysterols and Their Sulfate Analogs
HK1251216A1 (en) Methods for preparation of bile acids and derivatives thereof
JPH10251294A (ja) シス−ステロール化合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: new jersey

Applicant after: INTERCEPT PHARMACEUTICALS, Inc.

Address before: New York, United States

Applicant before: INTERCEPT PHARMACEUTICALS, Inc.

CB02 Change of applicant information